Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.560
+0.130 (5.35%)
At close: Mar 5, 2026, 4:00 PM EST
2.561
+0.001 (0.04%)
After-hours: Mar 5, 2026, 7:47 PM EST
Century Therapeutics Employees
As of December 31, 2024, Century Therapeutics had 150 total employees, including 140 full-time and 10 part-time employees. The number of employees decreased by 15 or -9.09% compared to the previous year.
Employees
150
Change (1Y)
-15
Growth (1Y)
-9.09%
Revenue / Employee
$755,580
Profits / Employee
-$176,547
Market Cap
459.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 150 | -15 | -9.09% |
| Dec 31, 2023 | 165 | -19 | -10.33% |
| Dec 31, 2022 | 184 | -4 | -2.13% |
| Dec 31, 2021 | 188 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| REGENXBIO | 353 |
| Lyell Immunopharma | 300 |
| 4D Molecular Therapeutics | 227 |
| Kyverna Therapeutics | 129 |
| Lineage Cell Therapeutics | 77 |
| Altimmune | 59 |
| Anavex Life Sciences | 34 |
IPSC News
- 8 days ago - Century Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 17 days ago - IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewsWire
- 24 days ago - Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
- 3 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 5 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire